Agios Pharmaceuticals | Créanciers Commerciaux



Trade Creditors Changement Date
AbbVie 2.94B 2.66B 2024-12
Agios Pharmaceuticals USD 16.64M 500K 2024-12
Alnylam Pharmaceuticals USD 88.42M 17.61M 2024-12
Amgen USD 1.91B 239M 2024-12
Arrowhead Research USD 14.46M 3.07M 2024-12
Astellas Pharma JPY 204.3B 43.14B 2024-12
AstraZeneca 22.46B 781M 2024-12
Bayer EUR 7.52B 957M 2024-12
Biogen USD 424.2M 1.5M 2024-12
BioMarin Pharmaceutical 715.66M 458.25M 2024-09
Bristol-Myers Squibb USD 3.6B 133M 2024-12
Daiichi Sankyo JPY 564.47B 61.64B 2024-12
Eli Lilly USD 3.23B 342.1M 2024-12
Exelixis USD 38.19M 21.12M 2025-01
Gilead Sciences USD 833M 70M 2024-12
GlaxoSmithKline 15.34B 960M 2024-12
Incyte USD 197.46M 18.76M 2024-12
Ionis Pharmaceuticals USD 42.96M 33.91M 2024-12
Merck USD 4.08B 493M 2024-12
Moderna USD 405M 32M 2024-12
Novartis USD 4.57B 485M 2024-12
Novartis USD 4.57B 485M 2024-12
Pfizer USD 5.63B 319M 2024-12
Regeneron Pharmaceuticals USD 4.89B 4.39B 2024-12
Roche Holding 4.35B 828M 2024-12
Sarepta Therapeutics USD 214.44M 95.67M 2024-12
Vertex Pharmaceuticals USD 413M 17.2M 2024-12



Agios Pharmaceuticals Créanciers Commerciaux - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.